DENVER, Nov. 19, 2013 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP) a leading international, award-winning sports nutrition company, announced today that its popular Amino 1 recovery and hydration sports drink will be available at 150 Costco locations nationwide mid-January 2014.
(Logo: http://photos.prnewswire.com/prnh/20130715/LA46954LOGO)
MusclePharm is strengthening its relationship with Costco as Amino 1 will be the second MusclePharm product line sold at the national retail giant following the announcement of the availability of Combat Protein Powder at all Costco locations earlier this year. MusclePharm is continuing to grow its presence beyond the specialty sports and nutrition market into wider reaching mass consumer distribution channels. Costco will carry Amino 1's tasty "Fruit Punch" flavor in an exclusive 60 serving size.
"Amino 1 is one of our most highly regarded product lines and was awarded Recovery Supplement of the Year & Amino Supplement of the Year, which is why we want to make it more easily accessible to fitness enthusiasts nationwide," said Brad Pyatt, founder and CEO, MusclePharm. "Our partnership with Costco also allows us to offer Amino 1 at a great value with the exclusive 60 serving size."
MusclePharm's Amino 1 is among the most effective recovery and hydration products on the market. It's formulated to increase stamina, rebuild muscle and speed up recovery time. Endurance and muscle building is achieved through 10,000 mg of amino acids patent pending 3:1:2 ratio instantized BCAAs while recovery is supported through Amino 1's ability to deliver nutrients through multiple pathways. MusclePharm's fine-tuned electrolyte hydration system maximizes rehydration through coconut water concentrate making Amino 1 a comprehensive in-workout sports drink.
ABOUT MUSCLEPHARM CORPORATION:
MusclePharm® is a leading international, award-winning sports nutrition company offering vitamins and nutritional supplements which are available in more than 110 countries and available in 15,000+ U.S. retail outlets, including Costco, Dick's Sporting Goods, 24 Hour Fitness, Bally's, GNC, Vitamin Shoppe and Vitamin World. The company's brands are MusclePharm®, Arnold Schwarzenegger Series™, and FitMiss™. The comprehensive lines of clinically-proven, safe and effective nutritional supplements are developed through a six-stage research process that utilizes the expertise of leading nutritional scientists, doctors and universities. For more information, visit www.musclepharm.com. Follow the company at http://www.facebook.com/MusclePharm and www.Twitter.com/MusclePharm.
Forward Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
MusclePharm PR Contact:
Ivy Mollenkamp/Amy Pandya
Rogers & Cowan
310-854-8131/310-854-8262
imollenkamp@rogersandcowan.com
apandya@rogersandcowan.com
SOURCE MusclePharm Corporation